Your browser doesn't support javascript.
loading
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
Sankhala, Kamalesh; Takimoto, Chris H; Mita, Alain C; Xiong, Henry; Rodón, Jordi; Mehrvarz Sarshekeh, Amir; Burns, K; Iizuka, Kenzo; Kopetz, Scott.
Afiliação
  • Sankhala K; Cedars-Sinai Medical Center, Beverly Hills, CA, USA.
  • Takimoto CH; Institute for Drug Development, Cancer Therapy & Research Center, San Antonio, TX, USA.
  • Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Xiong H; The Center for Cancer and Blood Disorders/SCRI, Fort Worth, TX, USA.
  • Rodón J; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mehrvarz Sarshekeh A; Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Burns K; Institute for Drug Development, Cancer Therapy & Research Center, San Antonio, TX, USA.
  • Iizuka K; Delta-Fly Pharma Inc., Tokushima, Japan.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. skopetz@mdanderson.org.
Invest New Drugs ; 37(1): 76-86, 2019 02.
Article em En | MEDLINE | ID: mdl-29667134

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desoxicitidina / Isoflurofato / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desoxicitidina / Isoflurofato / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article